These results determine that the exosomal Rab22a-NeoF1 fusion protein promotes cell migration, invasion, and metastasis of its negative recipient cells via activation of RhoA by PYK2 from donor cells in osteosarcoma. Here, RAB22A is linked to osteosarcoma.